(Q36311034)

13 August 2017

1 reference

title

Pharmacotherapy of comorbid mood, anxiety, and substance use disorders (English)

1 reference

13 August 2017

0 references

0 references

Kathleen T Brady

1

1 reference

13 August 2017

Marcia L Verduin

series ordinal

2

1 reference

13 August 2017

publication date

1 January 2005

1 reference

13 August 2017

published in

Substance Use and Misuse

1 reference

13 August 2017

volume

40

1 reference

13 August 2017

issue

13-14

1 reference

13 August 2017

page(s)

2021-41, 2043-8

1 reference

Adherence to lithium prophylaxis: II. Multivariate analysis of clinical, social, and psychosocial predictors of nonadherence.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Zimeldine: a review of its effects on ethanol consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Advances in the psychosocial treatment of anxiety disorders. Implications for national health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Clinical correlates of therapeutic response in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Substance Abuse in an Inpatient Psychiatric Sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

A randomized trial of sertraline as a cessation aid for smokers with a history of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Cocaine use and other suspected risk factors for obsessive-compulsive disorder: a prospective study with data from the Epidemiologic Catchment Area surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Drug therapy of post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Screening and diagnosis of anxiety and mood disorders in substance abuse patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

The effects of zimeldine on voluntary ethanol consumption: studies on the mechanism of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Substance use disorders in patients with posttraumatic stress disorder: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Posttraumatic stress disorder in the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Recent developments in the psychopharmacology of anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

How well do clinicians estimate patients' adherence to combination antiretroviral therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Venlafaxine treatment of cocaine abusers with depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Psychiatric comorbidity: prevalence in methadone maintenance treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Treatment of social phobia with gabapentin: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Double-blind clinical trial of sertraline treatment for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Paroxetine for social anxiety and alcohol use in dual-diagnosed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Fluoxetine in drug-dependent delinquents with major depression: an open trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Cocaine-Associated Panic Attacks in Methadone-Maintained Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Psychiatric diagnoses of treatment-seeking cocaine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Potential use of olanzapine in treatment of substance dependence disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Fluoxetine treatment of cocaine-dependent patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

The role of the endogenous opioid system in the pathogenesis of anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

The effect of bupropion on nicotine craving and withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Targeting smokers at increased risk for relapse: treating women and those with a history of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Treatment of cocaine-induced panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

Treatment of Depressed Methadone Maintenance Patients with Nefazodone:A Case Series

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294924

10.1080/10826080500294924

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference